Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT00106821. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8 Week Randomized, Placebo Controlled, Double-blind Study to Assess the Efficacy of Tiotropium Inhalation Capsules in Patients of African Descent With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.
Study identification
- NCT ID
- NCT00106821
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 166 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2004 (Type not available)
- Primary completion
- Aug 2005 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 1, 2013
Started 2004
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| Cooper Green Hospital | Birmingham | Alabama | — | — |
| University of Alabama at Birmingham | Birmingham | Alabama | — | — |
| David Geffen School of Medicine | Los Angeles | California | — | — |
| VA Greater Los angeles Health Care Systems | Sepulveda | California | — | — |
| Boehringer Ingelheim Investigational Site | Waterbury | Connecticut | — | — |
| Yale Univ. Pulmonary and Critical Care Medicine | West Haven | Connecticut | — | — |
| Emerald Coast Research Associates | Panama City | Florida | — | — |
| Bay Pines V. A. Medical Center | Saint Petersberg | Florida | — | — |
| Louisiana State University School of Medicine | New Orleans | Louisiana | — | — |
| LSU MC-Sheveport | Shreveport | Louisiana | — | — |
| Bronx VA Medical Center | The Bronx | New York | — | — |
| Brody School of Medicine, East Carolina University | Greenville | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| Temple University Hospital | Philadelphia | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | — | — |
| Attention: Amir Sharafkhaneh, M.D. | Houston | Texas | — | — |
| VAMC Houston | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00106821, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2013 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00106821 live on ClinicalTrials.gov.